Evidence map›Paper›PMID 29323230›Full record

ArticleScientific reports2018

Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae.

Marcus Nguyen, Thomas Brettin, S Wesley Long, James M Musser, Randall J Olsen, Robert Olson, Maulik Shukla, Rick L Stevens, Fangfang Xia, Hyunseung Yoo and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Prediction of antimicrobial resistance inMicrobiology spectrum · 2025
    Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marcus NguyenNorthern Illinois University, Computation Science, DeKalb, IL, 60115, USA.
Thomas BrettinUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
S Wesley LongCenter for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, Texas, 77030, USA.ORCID http://orcid.org/0000-0003-3043-5307
James M MusserCenter for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, Texas, 77030, USA.
Randall J OlsenCenter for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute and Houston Methodist Hospital, Houston, Texas, 77030, USA.
Robert OlsonUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
Maulik ShuklaUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
Rick L StevensUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
Fangfang XiaUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
Hyunseung YooUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA.
James J DavisUniversity of Chicago, Computation Institute, Chicago, IL, 60637, USA. jjdavis@anl.gov.

Funding

NIAID NIH HHS HHSN272201400027C
6 · The paper itself

Abstract

Antimicrobial resistant infections are a serious public health threat worldwide. Whole genome sequencing approaches to rapidly identify pathogens and predict antibiotic resistance phenotypes are becoming more feasible and may offer a way to reduce clinical test turnaround times compared to conventional culture-based methods, and in turn, improve patient outcomes. In this study, we use whole genome sequence data from 1668 clinical isolates of Klebsiella pneumoniae to develop a XGBoost-based machine learning model that accurately predicts minimum inhibitory concentrations (MICs) for 20 antibiotics. The overall accuracy of the model, within ±1 two-fold dilution factor, is 92%. Individual accuracies are ≥90% for 15/20 antibiotics. We show that the MICs predicted by the model correlate with known antimicrobial resistance genes. Importantly, the genome-wide approach described in this study offers a way to predict MICs for isolates without knowledge of the underlying gene content. This study shows that machine learning can be used to build a complete in silico MIC prediction panel for K. pneumoniae and provides a framework for building MIC prediction models for other pathogenic bacteria.

Indexed as

Anti-Bacterial AgentsComputer SimulationDNA, BacterialDrug Resistance, Multiple, BacterialHumansKlebsiella InfectionsKlebsiella pneumoniaeMachine LearningMicrobial Sensitivity TestsModels, TheoreticalWhole Genome SequencingAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID29323230
PMCPMC5765115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.